dockets: FDA-2017-P-4039

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
FDA-2017-P-4039 FDA Requests that the FDA foster a transition to opioid analgesics with abuse-deterrent labeling (ADOs) by requiring manufacturers of certain oral opioid analgesics not in abuse-deterrent formulations to convert their products to ADOs within three years of the date of this Citizen Petition or else have their products removed from the market on July 3, 2020 Nonrulemaking 2019-07-08T09:21:40Z 0b000064827de8f4   OPEN     ["Citizen Petition", "CDER- ORP", "Center for Lawful Access and Abuse Deterrence", "abuse-deterrent labe ling (ADOs)", "oral opioid analgesics", "immediate-release (IR)", "three oral, extended-release/long-acting (ERILA)", "Open"] CDER Convert their products to ADOs within three years of the date of this Citizen Petition or else have their products removed from the market on July 3, 2020     {"displayProperties": [{"name": "abstract", "label": "General Information", "tooltip": "Describes an agency's specific regulatory action; equivalents: Abstract, Description, Docket Subject, Related To, Summary."}, {"name": "generic", "label": "Docket Item Code", "tooltip": "An agency specific code that identifies the type of document that established the docket (regulatory action)."}, {"name": "program", "label": "Center", "tooltip": "The agency specific program associated with the docket (regulatory action); equivalents: Docket Item Code, Location."}, {"name": "field2", "label": "Docket Status", "tooltip": "Used to Identity that a Docket's Status is Open or Closed"}, {"name": "shortTitle", "label": "Short Title", "tooltip": "A combination of letters and or numbers assigned to an agency's regulatory action for purposes of brevity."}], "keywords": ["Citizen Petition", "CDER- ORP", "Center for Lawful Access and Abuse Deterrence", "abuse-deterrent labe ling (ADOs)", "oral opioid analgesics", "immediate-release (IR)", "three oral, extended-release/long-acting (ERILA)", "Open"], "modifyDate": "2019-07-08T09:21:40Z", "dkAbstract": "OPEN", "agencyId": "FDA", "program": "CDER", "shortTitle": "Convert their products to ADOs within three years of the date of this Citizen Petition or else have their products removed from the market on July 3, 2020", "subType2": null, "title": "Requests that the FDA foster a transition to opioid analgesics with abuse-deterrent labeling (ADOs) by requiring manufacturers of certain oral opioid analgesics not in abuse-deterrent formulations to convert their products to ADOs within three years of the date of this Citizen Petition or else have their products removed from the market on July 3, 2020", "generic": "P", "field1": null, "docketType": "Nonrulemaking", "petitionNbr": null, "rin": null, "organization": null, "legacyId": null, "subType": null, "category": null, "field2": "Open", "effectiveDate": null, "objectId": "0b000064827de8f4"} single_get

Links from other tables